文献速递炎症性肠病消化道肿瘤与早癌

炎症性肠病相关结直肠癌的遗传与表观遗传特征

Genetic and Epigenetic Characteristics of Inflammatory Bowel Disease-Associated Colorectal Cancer.
PubMed 文献 · Gastroenterology · 2021-04-27

该研究对31例炎症性肠病相关结直肠癌(IBD-CRC)的肿瘤及正常组织进行全基因组测序、SNP阵列、RNA测序、全基因组甲基化分析和免疫组化,并与散发性结直肠癌(sCRC)数据比较。结果显示IBD-CRC完全缺乏WNT信号相关的经典上皮亚型,以间质富集亚型为主,AXIN2和RNF43显著下调,HNF4A增益频率较低,TP53 5'UTR非编码突变富集,APC和KRAS突变频率低于sCRC。结论提示IBD-CRC存在独特的WNT通路失调机制,可能影响预后和治疗选择。

要点

  • IBD-CRC以间质富集亚型为主,缺乏WNT相关的经典上皮亚型。
  • AXIN2和RNF43在IBD-CRC中显著下调,APC和KRAS突变频率低于sCRC。
  • TP53 5'UTR非编码突变在IBD-CRC中显著富集。

核心结论

  • IBD-CRC存在独特的WNT通路失调机制,使其倾向于间质肿瘤亚型,可能影响预后和治疗选择。
  • OSMR信号增强可能促进IBD患者中间质肿瘤的形成。

研究设计与样本

  • 对31例IBD-CRC患者的肿瘤和对应正常组织(新鲜冷冻和福尔马林固定样本)进行全基因组测序、SNP阵列、RNA测序、全基因组甲基化分析和免疫组化。
  • 将结果与内部sCRC数据集进行比较。

主要发现

  • 基于转录组的肿瘤亚型分析显示IBD-CRC中完全缺乏WNT信号相关的经典上皮肿瘤亚型,以间质富集亚型为主。
  • 负性WNT调节因子AXIN2和RNF43在IBD-CRC中强烈下调,HNF4A(WNT诱导EMT的负调节因子)的染色体增益频率低于sCRC。
  • HNF4α结合位点的低甲基化富集仅在sCRC基因组中检测到。
  • 参与黏膜免疫的PIGR和OSMR在IBD-CRC中通过表观遗传修饰发生失调。
  • 全基因组分析显示IBD-CRC中TP53 5'非翻译区的非编码突变显著富集,且APC和KRAS体细胞突变频率低于sCRC。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Inflammatory bowel disease (IBD) is a chronic, relapsing inflammatory disorder associated with an elevated risk of colorectal cancer (CRC). IBD-associated CRC (IBD-CRC) may represent a distinct pathway of tumorigenesis compared to sporadic CRC (sCRC). Our aim was to comprehensively characterize IBD-associated tumorigenesis integrating multiple high-throughput approaches, and to compare the results with in-house data sets from sCRCs. METHODS: Whole-genome sequencing, single nucleotide polymorphism arrays, RNA sequencing, genome-wide methylation analysis, and immunohistochemistry were performed using fresh-frozen and formalin-fixed tissue samples of tumor and corresponding normal tissues from 31 patients with IBD-CRC. RESULTS: Transcriptome-based tumor subtyping revealed the complete absence of canonical epithelial tumor subtype associated with WNT signaling in IBD-CRCs, dominated instead by mesenchymal stroma-rich subtype. Negative WNT regulators AXIN2 and RNF43 were strongly down-regulated in IBD-CRCs and chromosomal gains at HNF4A, a negative regulator of WNT-induced epithelial-mesenchymal transition (EMT), were less frequent compared to sCRCs. Enrichment of hypomethylation at HNF4α binding sites was detected solely in sCRC genomes. PIGR and OSMR involved in mucosal immunity were dysregulated via epigenetic modifications in IBD-CRCs. Genome-wide analysis showed significant enrichment of noncoding mutations to 5'untranslated region of TP53 in IBD-CRCs. As reported previously, somatic mutations in APC and KRAS were less frequent in IBD-CRCs compared to sCRCs. CONCLUSIONS: Distinct mechanisms of WNT pathway dysregulation skew IBD-CRCs toward mesenchymal tumor subtype, which may affect prognosis and treatment options. Increased OSMR signaling may favor the establishment of mesenchymal tumors in patients with IBD.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Rajamäki K, Taira A, Katainen R, et al. Genetic and Epigenetic Characteristics of Inflammatory Bowel Disease-Associated Colorectal Cancer. Gastroenterology. 2021. PMID: 33930428. doi:10.1053/j.gastro.2021.04.042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。